Cargando…
The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study
BACKGROUND: Human papillomavirus (HPV) vaccination and the implementation of primary HPV screening in the Netherlands will lead to a lower cervical disease burden. For evaluation and further improvement of prevention, it is important to estimate the magnitude and timing of health benefits of current...
Autores principales: | Matthijsse, Suzette M., Naber, Steffie K., Hontelez, Jan A. C., Bakker, Roel, van Ballegooijen, Marjolein, Lansdorp-Vogelaar, Iris, de Kok, Inge M. C. M., de Koning, Harry J., van Rosmalen, Joost, de Vlas, Sake J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122803/ https://www.ncbi.nlm.nih.gov/pubmed/30180203 http://dx.doi.org/10.1371/journal.pone.0202924 |
Ejemplares similares
-
The Role of Acquired Immunity in the Spread of Human Papillomavirus (HPV): Explorations with a Microsimulation Model
por: Matthijsse, Suzette M., et al.
Publicado: (2015) -
The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study
por: Naber, Steffie K., et al.
Publicado: (2016) -
Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012) -
Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
por: Naber, Steffie K., et al.
Publicado: (2016) -
Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates
por: Rozemeijer, Kirsten, et al.
Publicado: (2015)